Evidence map›Paper›PMID 34552697›Full record

ReviewWorld journal of hepatology2021

Therapeutic plasma exchange in liver failure.

Abimbola Chris-Olaiya, Aanchal Kapoor, Kristin S Ricci, Christina C Lindenmeyer

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. The right patient, the right time: Revisiting plasma exchange in HAV-related acute liver failure.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Management of acute liver failure-an updated literature review.World journal of critical care medicine · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Potential therapies for acute-on-chronic liver failure.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Review
  11. Article
  12. Review
  13. Dengue-related acute liver failure-A scoping review.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. [Therapeutic plasma exchange in the pediatric intensive care unit: a single-center retrospective study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  20. Hemoperfusion: technical aspects and state of the art.Critical care (London, England) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abimbola Chris-OlaiyaDepartment of Critical Care, Cleveland Clinic, Cleveland, OH 44195, United States.
Aanchal KapoorDepartment of Critical Care, Cleveland Clinic, Cleveland, OH 44195, United States.
Kristin S RicciDepartment of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, United States.
Christina C LindenmeyerDepartment of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States. lindenc@ccf.org.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multi-organ failure syndrome associated with acute and acute-on-chronic liver failure (ACLF) is thought to be mediated by overwhelming systemic inflammation triggered by both microbial and non-microbial factors. Therapeutic plasma exchange (TPE) has been proven to be an efficacious therapy in autoimmune conditions and altered immunity, with more recent data supporting its use in the management of liver failure. Few therapies have been shown to improve survival in critically ill patients with liver failure who are not expected to survive until liver transplantation (LT), who are ineligible for LT or who have no access to LT. TPE has been shown to reduce the levels of inflammatory cytokines, modulate adaptive immunity with the potential to lessen the susceptibility to infections, and reduce the levels of albumin-bound and water-bound toxins in liver failure. In patients with acute liver failure, high volume TPE has been shown to reduce the vasopressor requirement and improve survival, particularly in patients not eligible for LT. Standard volume TPE has also been shown to reduce mortality in certain sub-populations of patients with ACLF. TPE may be most favorably employed as a bridge to LT in patients with ACLF. In this review, we discuss the efficacy and technical considerations of TPE in both acute and acute-on-chronic liver failure.

Indexed as

Acute liver failureAcute-on-chronic liver failureCirrhosisCytokinesHigh volume plasma exchangeLiver transplantationTherapeutic plasma exchange

Identifiers

PMID34552697
PMCPMC8422921
OpenAlexW3194968616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.